Piper Jaffray upgrades St. Jude Medical (NYSE: STJ) from Neutral to Overweight with a $44 price target.

The firm commented, "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE